WebNov 18, 2024 · patient; and health care costs.3 The incidence rates of VAP are higher in developing countries with limited resources. Two studies from India have shown VAP rates of 32.5% and 20% in children ventilated in Pediatric Intensive Care Units (PICU).4,5 In a study from north India, the incidence of VAP was reported as 17.5/100 patients.6 In Egypt, a WebMar 22, 2024 · In 2024, the sales volume of electronic cigarettes in India reached over three million units. While this was a significant increase compared to 2014, China ranked highest within the market in...
Ventilator-Associated Pneumonia in Pediatric Intensive Care Unit
WebSep 9, 2024 · In India, six lakh cases of VAP are registered every year. VAP, if not diagnosed at an early stage, can prove fatal and mortality can range from 18 per cent to 50 per cent. It is, in fact,... WebFeb 1, 2003 · The authors investigated the incidence, risk factors, outcome, and pathogens of VAP in the cardiac surgical ICU. The estimated prevalence of nosocomial pneumonia in intensive care units ranges from 10% to 65% with mortality rates of 13% to 55%. 1 Nosocomial pneumonia was diagnosed in 25 (2.6%) of the 952 patients in this study. good life webster city ia
Incidence, bacteriology, and clinical outcome of ... - Europe PMC
Webat it is a well preventable disease and a proper approach decreases the hospital stay, cost, morbidity and mortality. The aim of the study is to critically review the incidence and outcome, identify various risk factors and conclude specific measures that should be undertaken to prevent VAP. We studied 100 patients randomly, kept on ventilatory support … WebSep 8, 2024 · Existing literature from Indian studies suggests an incidence of VAP ranging from 13–42%, and is highly variable in different regions. The sample size (n) is calculated according to the formula: n = z2 X P (1-p)/d2. Where: z = 1.96 for a confidence level (α) of 95%, p = proportion (0.4) and d = 0.06. Study subjects WebThe baseline incidence of VAP in Phase 1 was 28.8 (45/1559 × 1000), and in Phase 3, the incidence of VAP increased to 35.1 (48/1369 × 1000), and this difference was not statistically significant. However, the incidence of CLABSI was 7.9 (10/1267 × 1000) in Phase 1 and it decreased significantly to 1.7 (2/1153 × 1000) [Table 2]. good life webster city